The glucagonostatic effect of GLP-1 seems equally important as its insulinotropic action for the glucose-lowering effect of exogenous GLP-1 in patients with type 2 diabetes [79]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.